Comparison of standard triple therapy, sequential therapy and moxifloxacin-based triple therapy for Helicobacter pylori infection: Patients' compliance and bacterial eradication rates


RAKICI H. , Akdogan R. A. , BEDIR R. , Copur A. , YILMAZ A.

JOURNAL OF DIGESTIVE DISEASES, vol.15, no.9, pp.508-513, 2014 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 15 Issue: 9
  • Publication Date: 2014
  • Doi Number: 10.1111/1751-2980.12171
  • Title of Journal : JOURNAL OF DIGESTIVE DISEASES
  • Page Numbers: pp.508-513
  • Keywords: eradication rate, Helicobacter pylori, moxifloxacin, patients' compliance, resistance, QUADRUPLE THERAPY, 2ND-LINE TREATMENT, RANDOMIZED-TRIAL, METAANALYSIS, PREVALENCE, RESISTANCE, 1ST-LINE, CLARITHROMYCIN, LEVOFLOXACIN, GUIDELINES

Abstract

ObjectiveTo compare the patients' compliance with and the efficacy of existing treatments for Helicobacter pylori eradication, including moxifloxacin-based triple therapy, sequential treatment and the standard treatment.